XenoGesis will be the next tenant to move into BioCity Nottingham’s state-of-the-art Discovery Building, with the support of grant funding from the Government’s Regional Growth Fund and the University of Derby Invest to Grow Program. XenoGesis is an independent laboratory-based contract research organization specialized in preclinical drug metabolism and pharmacokinetics (DMPK), quantitative bioanalysis, in vitro pharmacology and modeling & simulation for human PK and dose prediction.  ...